Diabetes. Diabetes mellitus due to underlying condition
Conditions
Interventions
Intervention group: patients with prediabetes and type 2 diabetes under treatment for three months.
Sponsors
Kerman University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Diabetes type 2 or prediabet The level of HBA1c? 0.5-1% more than the target set for the patient Not receiving medication to control diabetes
Exclusion criteria
Exclusion criteria: Diabetes type 1 Hypo or hyperthyroidism Consumption of levothyroxine or methimazole Use of insulin or diabetes control drugs (biguanides? sulfonylureas? thiazolideones? SGLT2- inhibitors? GLP-1 receptor agonists? bromocriptine? cholestyramine? Dapaglifluzin GFR<30 A history of diabetic ketoacidosis or any underlying disease that predisposes a person to acidosis. History of liver failure Patients who are treated with other drugs affecting the metabolism of thyroid hormones (Amiodarone? Lithium? Androgen? Estrogen)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum thyroid stimulating hormone level. Timepoint: Before starting the study and after three months taking of empagliflozin. Method of measurement: Blood sampling. | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum T4 level. Timepoint: Before starting the study and after three months taking of empagliflozin. Method of measurement: Blood sampling. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMojgan Sanjari
Kerman University of Medical Sciences
Outcome results
None listed